Brief: Diamyd Medical Says Immunological Analysis Of Phase IIB Trial With Diamyd Show Differences Between Genetically Defined Patient Groups
19/12/2020 17:22
Dec 19 (Reuters) - Diamyd Medical AB DMYDb.ST :
* IMMUNOLOGICAL ANALYSIS OF PHASE IIB TRIAL WITH DIAMYD ®
SHOW
DIFFERENCES BETWEEN GENETICALLY DEFINED PATIENT GROUPS
* DIAMYD MEDICAL - RESULTS ARE IN LINE WITH EARLIER OBSERVED
DIFFERENCE IN CLINICAL RESPONSE BETWEEN INDIVIDUALS POSITIVE OR
NEGATIVE FOR HLA TYPE DR3-DQ2
Source text for Eikon: ID:nWkr2818pG
Further company coverage: DMYDb.ST
((Reuters.Briefs@thomsonreuters.com;))